New Lymphoma Study Findings Recently Were Reported by Researchers at ... HispanicBusiness.com Twenty-four patients were enrolled prospectively and were treated with unlabeled rituximab 70 mg and a therapeutic activity (median 7.3 GBq) of I-131 -rituximab." The news correspondents obtained a quote from the research from the Institute of ... |
